MultiCell Technologies, Inc. (MCET)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
MultiCell Technologies Market Cap
MultiCell Technologies has a market cap or net worth of $5.00 thousand as of August 22, 2025. Its market cap has decreased by -99.00% in one year.
Market Cap
5.00K
Enterprise Value
n/a
Revenue
805.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 24, 1995, MultiCell Technologies's market cap has decreased from 1.53M to 5.00K, a decrease of -99.67%. That is a compound annual growth rate of -17.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 5.00K | - |
| Dec 31, 2024 | 5.00K | - |
| Dec 27, 2023 | 5.00K | - |
| Dec 30, 2022 | 5.00K | - |
| Dec 31, 2021 | 5.00K | -99.67% |
| Dec 31, 2020 | 1.50M | 29,899.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |